Literature DB >> 9569002

Subtyping of Campylobacter jejuni Penner heat-stable (HS) serotype 11 isolates from human infections.

E Slater1, R J Owen.   

Abstract

High resolution molecular subtyping was applied to Campylobacter jejuni Penner heat-stable (HS) 11 isolates from human infections and other sources. Strains were genotyped by restriction fragment length polymorphism analysis involving PCR-based flagellin gene (flaA) profiling with HinfI and DdeI, and pulsed-field gel electrophoretic (PFGE) profiling with SmaI and KpnI. Fla-genes of the strains were highly conserved as most (95%) had the same fla-profile. PFGE analysis of SmaI digests was more discriminatory with 15 profile subtypes identified, although 36% of isolates had a common profile. The study showed that strains of C. jejuni HS11, unlike those of HS1 and the HS4 complex, were relatively homogeneous at the genomic level and that high resolution molecular techniques were essential for detailed epidemiological subtyping.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9569002     DOI: 10.1099/00222615-47-4-353

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  3 in total

1.  Phenotypic and genotypic diversity of the flagellin gene (fliC) among Clostridium difficile isolates from different serogroups.

Authors:  A Tasteyre; T Karjalainen; V Avesani; M Delmée; A Collignon; P Bourlioux; M C Barc
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

2.  Multilocus sequence typing system for Campylobacter jejuni.

Authors:  K E Dingle; F M Colles; D R Wareing; R Ure; A J Fox; F E Bolton; H J Bootsma; R J Willems; R Urwin; M C Maiden
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

3.  Evaluation of phenotypic and genotypic methods for subtyping Campylobacter jejuni isolates from humans, poultry, and cattle.

Authors:  E M Nielsen; J Engberg; V Fussing; L Petersen; C H Brogren; S L On
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.